advertisement
Editors Selection IGR 11-3
List of Editor's Selection comments by
Steve Kymes
Washington University School of Medicine, Department of Ophthalmology and Visual Sciences, St. Louis, MO, USA
Health Economics: Health technology assessment of OHT surveillance (14-2, February 2013) on:
50515 Surveillance for ocular hypertension: an evidence synthesis and economic evaluation
Burr JM; Botello-Pinzon P; Takwoingi Y et al.
Health Technol Assess 2012; 16: 1-271
Cost Effectiveness Review (11-3, December 2009) on:
24377 A critical review of the full economic evaluations of pharmacological treatments for glaucoma
Koleva D; De Compadri P; Virgili G et al.
Journal of Medical Economics 2008; 11: 719-741
Health Economics: Cost-effectiveness to test and treat (11-2, September 2009) on:
23859 The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States
Rein DB; Wittenborn JS; Lee PP et al.
Ophthalmology 2009; 116: 823-832
Health economics: Cost of screening (10-2, September 2008) on:
21097 Economic evaluation of screening for open-angle glaucoma
Hernandez RA; Burr JM; Vale LD
International Journal of Technology Assessment in Health Care 2008; 24: 203-211
Comments (10-1, July 2008) on:
20389 Cost-effectiveness of treating ocular hypertension
Stewart WC; Stewart JA; Nassar QJ et al.
Ophthalmology 2008; 115: 94-98
Health economics: Cost-effectiveness of tonometry (10-1, July 2008) on:
20827 Cost-effectiveness of early detection and treatment of ocular hypertension and primary open-angle glaucoma by the ophthalmologist
Peeters A; Schouten JS; Webers CA et al.
Eye 2008; 22: 354-362